HomeStrategic AdvisoryFinancingOur TeamNews & EventsContact Us
Green Bar Strategic Advisory
Partnering/Licensing Advisory Case Studies

M&A Sell-Side Engagements
BioPharma Capital, LLC has in-depth knowledge and global resources for emerging biopharma companies.
We can help you

• Refine your pitch using our deep expertise in the pharmaceutical industry and understanding of what resonates with
   potential acquirers
• Credibly articulate and validate your commercial opportunity by leveraging available third-party healthcare data and
• Target acquirers through our vast network in the life sciences industry

M&A Buy-Side Engagements
BioPharma Capital, LLC can leverage extensive experience with healthcare data to identify and evaluate acquisition targets to understand their full potential and aid in term sheet negotiations. Our deep connections with global and regional executives across the biopharma industry will give you rapid, targeted access to the right stakeholders and visibility into their willingness to engage in a transaction. Access to sales force data allows us to accurately model the impact of an acquisition on the business and financials, including potential resulting synergies.

Securities and Investment Banking Services are offered through Ashland Securities, LLC. Supervised by the Home Office, located at 80 S.W. 8th Street, Suite 2000 Miami, Florida 33130. Phone Number 305-279-3176. Member FINRA SIPC. Please refer to BrokerCheck for more information about Ashland Securities, LLC. BioPharma Capital, LLC and Ashland Securities, LLC are separate and unaffiliated entities.

Contact   |    Privacy    |    Terms of Use

©2016 BioPharma Capital

BioPharma Capital, LLC   La Jolla, CA   USA
Phone: +1 619 208-8439